Hsa-mir-22-3p inhibits liver cancer cell emt and cell migration/ invasion by indirectly regulating spry2

HIGHLIGHTS

• who: Shuaishuai Cui et al. from the School of Life and Medicine, Shandong University of Technology, Zibo, China, School of Life have published the Article: Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2, in the Journal: PLOS ONE of 24/01/2023
• what: The authors demonstrated that miR-22 indirectly regulates SPRY2 by inhibiting CBL an E3 ligase for SPRY2 that has been confirmed. The authors focused the study on miR-22-3p, not miR-22-5p.
• how: The final quantitation result is presented . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.